Sitompul Pompini Agustina, Indriani Roza, Rusli Adria, Sundari Titi, Rosamarlina Rosamarlina, Hartono Teguh Sarry, Maemun Siti, Syahril Mohammad, Rudiatmoko Diar Riyanti, Setiawaty Vivi
Prof. Dr. Sulianti Saroso National Infectious Disease Hospital, Ministry of Health, Jakarta 14340, Indonesia.
Faculty of Medicine, Universitas Indonesia, Jakarta 10430, Indonesia.
Adv Med. 2022 Aug 29;2022:3455948. doi: 10.1155/2022/3455948. eCollection 2022.
Pneumonia is still a major global problem with high morbidity and mortality. The increasing number of pneumonia cases caused by bacteria, especially multidrug-resistant pathogens, increasing age of the population, patients with chronic disease (comorbid), and inappropriate antimicrobial therapy at initial administration make the treatment become less effective. These issues finally contribute to higher morbidity and mortality in cases of hospitalized pneumonia patients. Therefore, it is crucial to know the microbial pattern and select the therapy according to local antimicrobial sensitivity patterns.
A cross-sectional study was conducted for hospitalized pneumonia patients between January 2015 and December 2016 in Indonesia National Referral Infectious Disease Hospital. Data were collected from medical records to show patient characteristics, antimicrobial treatment data, culture examination, and bacterial sensitivity.
A total of 99 pneumonia patients required hospitalization and underwent sputum culture examination. The patients were mostly above 65 years old (32.3%) and male (57.6%). The most common comorbidities were pulmonary tuberculosis (21%), and the others were heart failure, chronic obstructive pulmonary disease (COPD), and HIV/AIDS. Based on the sputum culture, fungi were identified in most specimens (56%), while the bacteria identified were (14%), sp. (12%), and sp. (8%). Third-generation cephalosporin, such as ceftriaxone (50%), was commonly used as an antibiotic for pneumonia treatment.
Most common bacteria isolated from sputum culture were which were more sensitive to the beta-lactam and aminoglycoside groups. The higher risk factors were age above 65 years old, being male, and having tuberculosis.
肺炎仍然是一个全球性的重大问题,发病率和死亡率都很高。由细菌引起的肺炎病例数量不断增加,尤其是多重耐药病原体,人口老龄化,慢性病(合并症)患者,以及初始给药时抗菌治疗不当,使得治疗效果变差。这些问题最终导致住院肺炎患者的发病率和死亡率更高。因此,了解微生物模式并根据当地抗菌药物敏感性模式选择治疗方法至关重要。
对2015年1月至2016年12月在印度尼西亚国家转诊传染病医院住院的肺炎患者进行了一项横断面研究。从病历中收集数据,以显示患者特征、抗菌治疗数据、培养检查和细菌敏感性。
共有99例肺炎患者需要住院并接受痰培养检查。患者大多年龄在65岁以上(32.3%),男性(57.6%)。最常见的合并症是肺结核(21%),其他的是心力衰竭、慢性阻塞性肺疾病(COPD)和艾滋病毒/艾滋病。根据痰培养,大多数标本(56%)中鉴定出真菌,而鉴定出的细菌有 (14%)、 菌属(12%)和 菌属(8%)。第三代头孢菌素,如头孢曲松(50%),通常用作肺炎治疗的抗生素。
从痰培养中分离出的最常见细菌是 ,其对β-内酰胺类和氨基糖苷类更敏感。较高的危险因素是年龄在65岁以上、男性和患有肺结核。